NCT03754348View on ClinicalTrials.gov

Microglial Activation in Narcolepsy Type 1 and Kleine-Levin Syndrome: Positron Emission Tomography (PET) Study in [18F] DPA-714

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

November 18, 2021

Study Completion Date

November 18, 2021

Conditions
Narcolepsy 1Kleine-Levin Syndrome
Interventions
RADIATION

PET scan with tracer injection [18F] DPA-714

the subject will receive a dose of 3.5MBq / kg intravenous (in bolus) more or less 20%, knowing that the minimum dose injected is unchanged at 150MBq and the maximum dose at 370 MBq. Irradiation will remain below 10 mSv

Trial Locations (1)

Unknown

University Hospital of Montpellier, Montpellier

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire de Nīmes

OTHER

lead

University Hospital, Montpellier

OTHER

NCT03754348 - Microglial Activation in Narcolepsy Type 1 and Kleine-Levin Syndrome: Positron Emission Tomography (PET) Study in [18F] DPA-714 | Biotech Hunter | Biotech Hunter